NeoDynamics Full year report 2022 with all consolidated entities and the company secures financing for the launch of NeoNavia in the US.
Read full year report here: https://www.neodynamics.com/sv-se/tools/GetCisionNews?id=4469196&lang=eng
NeoDynamics announced yesterday that they secured financing for the launch of NeoNavia in the US from their largest shareholder Gryningkust Holding AB.
Read announcement with full transparency on terms for the loan here: https://www.neodynamics.com/sv-se/tools/GetCisionNews?id=4468681&lang=eng
Sigup to Q&A event with CFO Aaron Wong on the above topics plus rollout plans for the commercialization in US - Monday the 20th. of February 1 PM. here: https://hcandersencapital.dk/event/neodynamics-presentation-of-annual-accounts-2022/
HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. /Analyst Claus Thestrup 4:40 PM 02-17-2022.
Neodynamics
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Read more on company page